Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type Sort ascending
Focus Area
Country
Application Due Date
Cancer Registry
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Oncology Congo, The Democratic Republic
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease Australia, Canada, France, Germany, Italy, Japan, Korea, Spain
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines Italy
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Rare Disease Canada
Projects for Enhancing Regional Cancer Treatment
Release Date:
Partner: Japanese Society of Clinical Oncology
Review Process: Expert Review Panel
Translation: Japanese (link)
Quality Improvement Oncology Japan
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
Review Process: Expert Review Panel
Quality Improvement Rare Disease All
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Spain
Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Release Date:
Partner: Colorectal Cancer Canada (CCC)
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Title
Grant Type Sort ascending
Focus Area
Country
Application Due Date
Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient Care
Release Date:
Partner: The PROTEUS Consortium
Review Process: Expert Review Panel
Research Oncology USA
Real World Evidence of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology All
2023/2024 Global NASH ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Internal Medicine All
Diversity in Postmarketing Drug Safety Surveillance
Release Date:
Review Process: Pfizer Internal
Research Patient Safety USA
Improving Health Equity in IBD through Disparities Research
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology All
Burden of RSV Disease - Analyzing Local Surveillance Data for Older Adults (EM Geographic Scope)
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology All
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Rare Disease Canada
Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Japan, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Spain, Sweden, Switzerland, United Kingdom
Ulcerative Colitis (UC) Research
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Albania, Andorra, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Holy See (Vatican City State), Hungary, Iceland, Ireland, Israel, Italy, Korea, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
Novel Digital Diagnostic Approaches in Acromegaly and Sickle Cell Disease
Release Date:
Review Process: Pfizer Internal
Research Rare Disease USA
Alopecia Areata (Global)
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology USA
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Rare Disease Canada